## Abstract A highly potent renin inhibitor of the azapeptide type (2) is synthesized by starting from the hydrazine derivative 3. This peptide analogue inhibits renin in the same range (nanomolar) as its purely peptidic original 2a, but reveals much higher specificity for renin than 2a does.
Synthesis of a Renin Inhibitor of the Azapeptide Type
✍ Scribed by Gante, Joachim ;Kahlenberg, Harald
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 294 KB
- Volume
- 1989
- Category
- Article
- ISSN
- 0947-3440
No coin nor oath required. For personal study only.
✦ Synopsis
In 1962 "azapeptides" were described for the first time'). In these peptide analogs the a-CH group of one or more amino acid residues of a peptide chain is replaced with nitrogen.
📜 SIMILAR VOLUMES
## Abstract Boc‐hydrazine (1) was treated with 4‐nitrophenyl chloroformate (2) to give Boc‐Azagly 4‐nitrophenyl ester (3). Reaction of 3 with H‐ACHP‐Ile‐3‐pyridylmethylamide^5)^ (4) provided Boc‐Azagly‐ACHP‐Ile‐3‐pyridylmethylamide (5). This was deprotected with HCl/dioxane to give H‐Azagly‐ACHP‐Il
## Abstract In the search for a radioactive form of the peptidomimetic renin inhibitor, ditekiren, with a metabolically suitable radiolabel for conducting drug disposition studies, we prepared [^3^H]ditekiren with tritium labels in the N‐methyl‐histidine moiety and in the leu‐val alcohol transition